Interstitial Granulomatous Dermatitis With Arthritis Responding to Tocilizumab

被引:20
作者
Schanz, Stefan [1 ,3 ]
Schmalzing, Marc [2 ]
Guenova, Emmanuella [1 ,3 ]
Metzler, Gisela [1 ]
Ulmer, Anja [1 ]
Koetter, Ina [3 ]
Fierlbeck, Gerhard [1 ,3 ]
机构
[1] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Dept Internal Med 2, D-72076 Tubingen, Germany
[3] Univ Tubingen, Interdisciplinary Ctr Rheumatol Immunol & Autoimm, D-72076 Tubingen, Germany
关键词
ANTI-IL-6 RECEPTOR ANTIBODY; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; INTERLEUKIN-6; IL-6; DOUBLE-BLIND; TRIAL; DISEASE; SERUM;
D O I
10.1001/archdermatol.2011.341
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:17 / 20
页数:4
相关论文
共 17 条
[1]  
Ackerman AB., 1993, CLUE 78 CLUES DIAGNO, P309
[2]  
Busquets-Pérez N, 2006, J RHEUMATOL, V33, P1207
[3]   Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor α inhibitors [J].
Deng, A ;
Harvey, V ;
Sina, B ;
Strobel, D ;
Badros, A ;
Junkins-Hopkins, JM ;
Samuels, A ;
Oghilikhan, M ;
Gaspari, A .
ARCHIVES OF DERMATOLOGY, 2006, 142 (02) :198-202
[4]   Interstitial granulomatous dermatitis (Ackerman's syndrome) in SLE presenting with the 'rope sign' [J].
Dubey, S. ;
Merry, P. .
RHEUMATOLOGY, 2007, 46 (01) :80-80
[5]   A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease [J].
Ito, H ;
Takazoe, M ;
Fukuda, Y ;
Hibi, T ;
Kusugami, K ;
Andoh, A ;
Matsumoto, T ;
Yamamura, T ;
Azuma, J ;
Nishimoto, N ;
Yoshizaki, K ;
Shimoyama, T ;
Kishimoto, T .
GASTROENTEROLOGY, 2004, 126 (04) :989-996
[6]   IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation [J].
Kaplanski, G ;
Marin, V ;
Montero-Julian, F ;
Mantovani, A ;
Farnarier, C .
TRENDS IN IMMUNOLOGY, 2003, 24 (01) :25-29
[7]   Interleukin-6: From basic science to medicine - 40 years in immunology [J].
Kishimoto, T .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :1-21
[8]   Interstitial granulomatous dermatitis with arthritis [J].
Long, D ;
Thiboutot, DM ;
Majeski, JT ;
Vasily, DB ;
Helm, KF .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (06) :957-961
[9]   Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody - A multicenter, double-blind, placebo-controlled trial [J].
Nishimoto, N ;
Yoshizaki, K ;
Miyasaka, N ;
Yamamoto, K ;
Kawai, S ;
Takeuchi, T ;
Hashimoto, J ;
Azuma, J ;
Kishimoto, T .
ARTHRITIS AND RHEUMATISM, 2004, 50 (06) :1761-1769
[10]   Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease [J].
Nishimoto, Norihiro ;
Terao, Kimio ;
Mima, Toru ;
Nakahara, Hideko ;
Takagi, Nobuhiro ;
Kakehi, Takahiro .
BLOOD, 2008, 112 (10) :3959-3964